Director sold ~$198K of Exelixis
Scheduled in advanceTraded May 20, 2026 · Filed May 22, 2026
Exelixis's Commercial sold $1.6M of Exelixis shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,599,399
Shares × reported transaction price
15 days after results of May 5, 2026, 77 days before results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.9% | +1.2% | −4.1% |
| 30 days | +6.5% | −2.2% | +8.7% |
| 90 days | +9.1% | +1.7% | +7.4% |
Past results only. Not a forecast.
Director sold ~$198K of Exelixis
Scheduled in advanceDirector sold ~$492K of Exelixis
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.